DI STEFANO, ROSARIO FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.065
EU - Europa 763
AS - Asia 384
OC - Oceania 52
AF - Africa 48
SA - Sud America 21
Totale 2.333
Nazione #
US - Stati Uniti d'America 1.014
IT - Italia 211
CN - Cina 135
GB - Regno Unito 120
IE - Irlanda 120
SE - Svezia 69
AU - Australia 51
CA - Canada 40
ES - Italia 30
IR - Iran 29
KR - Corea 29
VN - Vietnam 28
IN - India 26
PL - Polonia 26
UA - Ucraina 26
HK - Hong Kong 24
SG - Singapore 22
BE - Belgio 20
TR - Turchia 20
DE - Germania 19
DK - Danimarca 19
JP - Giappone 19
FR - Francia 17
NL - Olanda 15
CH - Svizzera 11
ZA - Sudafrica 10
AT - Austria 9
PH - Filippine 9
BR - Brasile 8
FI - Finlandia 8
IQ - Iraq 8
KE - Kenya 8
ID - Indonesia 7
MX - Messico 7
NG - Nigeria 7
PK - Pakistan 7
TW - Taiwan 7
GH - Ghana 6
GR - Grecia 6
RS - Serbia 6
CO - Colombia 5
LT - Lituania 5
PT - Portogallo 5
CZ - Repubblica Ceca 4
MA - Marocco 4
NO - Norvegia 4
CL - Cile 3
EG - Egitto 3
HR - Croazia 3
LY - Libia 3
MY - Malesia 3
TN - Tunisia 3
VE - Venezuela 3
BJ - Benin 2
HU - Ungheria 2
KZ - Kazakistan 2
MT - Malta 2
NE - Niger 2
NI - Nicaragua 2
PR - Porto Rico 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BO - Bolivia 1
CY - Cipro 1
EC - Ecuador 1
IL - Israele 1
JO - Giordania 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 2.333
Città #
Chandler 193
Dublin 117
Fairfield 54
Nyköping 53
Ashburn 50
Beijing 45
Torino 36
Redwood City 32
Turin 31
Wilmington 26
Woodbridge 25
Seattle 22
London 21
Binbrook 20
Houston 20
Medford 20
New York 20
Pisa 20
Princeton 20
Kalundborg 18
Cambridge 17
Dong Ket 16
Peoria 16
Fremont 14
Warsaw 14
Hangzhou 13
Milan 13
Los Angeles 11
Dearborn 10
Seoul 10
Genoa 9
Guangzhou 9
Philadelphia 9
Istanbul 8
Singapore 8
Tokyo 8
Vienna 8
Adelaide 7
Boston 7
Brisbane 7
Central 7
Chennai 7
Gangdong-gu 7
Isfahan 7
Jacksonville 7
Liverpool 7
San Diego 7
Ann Arbor 6
Belgrade 6
Chengdu 6
Derby 6
Duncan 6
Hong Kong 6
Kraków 6
Madrid 6
Nairobi 6
Noblesville 6
Taipei 6
Wuhan 6
Bognor Regis 5
Bronx 5
Camden 5
Chicago 5
Davao City 5
Ghent 5
Hyderabad 5
Johannesburg 5
Melbourne 5
Shanghai 5
Sydney 5
Valencia 5
Abuja 4
Buffalo 4
Croydon 4
Jinan 4
Lappeenranta 4
Molenbeek-Saint-Jean 4
Moncalieri 4
Montreal 4
Odunpazari 4
Palo Alto 4
Perth 4
Piemonte 4
Rome 4
Tehran 4
Ankara 3
Athens 3
Bethesda 3
Cagliari 3
Central District 3
Coventry 3
Dagupan 3
Glasgow 3
Hebei 3
Helsinki 3
Islington 3
Kulmbach 3
Lagos 3
Manchester 3
Mont-Tremblant 3
Totale 1.339
Nome #
Hormonal treatment and quality of life of prostate cancer patients: new evidences 645
Renal cell carcinoma (RCC): Fatter is better? A review on the role of obesity in RCC 201
Deficiencies in health-related quality of life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016 155
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018 154
Fatigue in lung cancer patients: symptom burden and management of challenges. 130
Baseline chest X-ray in coronavirus disease 19 (COVID-19) patients: association with clinical and laboratory data 99
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018 91
SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit 87
LATITUDE and other coordinates in quality of life of prostate cancer patients 79
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate 77
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave 67
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018 55
Chemotherapy-Induced Neutropenia and Outcome in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With First-Line Docetaxel 53
Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences 47
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives 47
Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review 44
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis 39
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with Abiraterone or Enzalutamide 38
Prognostic factors in metastatic castration resistant prostate cancer patients treated with Radium-223: a retrospective study 37
Are tyrosine kinase inhibitors an effective treatment in testicular metastases from kidney cancer? Case report 36
New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? 32
Prognostic role of early PSa drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide 30
Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine? 29
Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications 29
Therapeutic sequencing in advanced renal cell carcinoma: how to choose considering clinical and biological factors 27
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy 25
New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond 23
How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy? 17
Navigating the ICI Combination Treatment Journey: Patterns of Response and Progression to First-Line ICI-Based Combination Treatment in Metastatic Renal Cell Carcinoma 7
Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer 6
Totale 2.406
Categoria #
all - tutte 7.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.876


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201940 0 0 0 0 0 0 0 0 0 0 29 11
2019/2020171 7 8 6 16 9 21 15 19 19 20 13 18
2020/2021335 12 17 33 33 39 25 26 33 30 27 17 43
2021/2022411 40 18 20 9 15 6 22 25 19 57 128 52
2022/2023852 52 90 33 59 84 152 57 63 99 51 65 47
2023/2024511 52 71 41 58 32 83 62 40 9 42 21 0
Totale 2.406